Myrad Genetics discovers novel anti-cancer drug
Compounds Selectively Activate Programmed Cell Death
11-Oct-2001 -
Salt Lake City, October 9, 2001
Myriad Genetics, Inc. has discovered a novel drug target for the treatment of a broad range of cancers, and has initiated lead optimization with a series of compounds that selectively kill cancer cells, the Company announced today. The anti-cancer target was ...
apoptosis
cell lines
chemotherapy
+11